MRNS Marinus Pharmaceuticals Inc

Marinus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders.

$19.28  +0.79 (4.27%)
As of 06/24/2021 15:59:41 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/31/2014
Outstanding shares:  36,633,490
Average volume:  189,843
Market cap:   $674,422,551
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    56854Q200
ISIN:        US56854Q2003
Sedol:      BM8MVZ3
Valuation   (See tab for details)
PE ratio:   -11.24
PB ratio:   6.11
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy